Log in with your email address username.


[Correspondence] Essential medicines for universal health coverage – Authors’ reply

The letter from Tetsuya Tanimoto and colleagues raises important questions that deserve a response. First, the WHO Member State Mechanism recommended in November, 2016, that the term counterfeit no longer be used to refer to quality-compromised medical products.1 The unwieldy term substandard, spurious, falsely labelled, falsified, counterfeit medical products, has been simplified to substandard and falsified medical products. In the case presented by Tanimoto and colleagues, the product appears to have been falsified.